XRCC5(X-ray repair cross-complementing protein 5)是参与DNA双链断裂修复的关键基因,编码Ku80蛋白(也称为Ku86)。Ku80与Ku70(由XRCC6基因编码)形成异源二聚体Ku复合体,作为DNA依赖性蛋白激酶(DNA-PK)的核心组分,在非同源末端连接(NHEJ)修复途径中起核心作用。NHEJ是细胞修复DNA双链断裂的主要机制,尤其在细胞周期G1期占主导地位。Ku复合体通过识别并结合断裂的DNA末端,招募DNA-PK催化亚基(DNA-PKcs)及其他修复蛋白(如Artemis、XRCC4、Ligase IV等),完成DNA末端的加工与连接。XRCC5/Ku80的特点包括其高度保守的环形结构域,能环绕DNA双链并稳定断裂末端,防止降解或错误重组。该基因突变会导致NHEJ功能缺陷,表现为基因组不稳定、辐射敏感性增加及免疫系统异常(因V(D)J重组障碍),与多种癌症(如淋巴瘤、乳腺癌)、免疫缺陷病及早衰综合征相关。过表达XRCC5可能增强DNA修复能力,降低突变积累,但可能促进肿瘤细胞抵抗放疗/化疗;而表达降低则导致修复缺陷,增加染色体畸变风险。XRCC5属于Ku基因家族(含XRCC5和XRCC6),家族成员均具有DNA末端结合特性,通过协同作用维持基因组稳定性。研究还发现XRCC5在端粒维护、转录调控及病毒感染防御中有额外功能,其表达水平变化可能通过影响其他修复基因(如TP53、BRCA1)的活性间接调控细胞凋亡或周期检查点。
The protein encoded by this gene is the 80-kilodalton subunit of the Ku heterodimer protein which is also known as ATP-dependant DNA helicase II or DNA repair protein XRCC5. Ku is the DNA-binding component of the DNA-dependent protein kinase, and it functions together with the DNA ligase IV-XRCC4 complex in the repair of DNA double-strand break by non-homologous end joining and the completion of V(D)J recombination events. This gene functionally complements Chinese hamster xrs-6, a mutant defective in DNA double-strand break repair and in ability to undergo V(D)J recombination. A rare microsatellite polymorphism in this gene is associated with cancer in patients of varying radiosensitivity. [provided by RefSeq, Jul 2008]
由该基因编码的蛋白质是喾异二聚体蛋白,其也被称为ATP依赖的DNA解旋酶II或DNA修复蛋白XRCC5的80千道尔顿亚单位。区是DNA依赖性蛋白激酶的DNA结合成分,并将其与在DNA双链断裂的通过非同源末端连接修复的DNA连接酶IV-XRCC4复杂和V的完成(D)的功能一起J重组事件。该基因功能的补充中国仓鼠XRS-6,在DNA双链断裂修复突变体缺陷并且在经过V(D)J重组的能力。在这个基因的罕见的微卫星多态性与癌症的放射敏感性不同的患者。 [由RefSeq的,2008年7月提供]
XRCC5基因(以及对应的蛋白质)的细胞分布位置:
XRCC5基因的本体(GO)信息:
名称 |
---|
3450 Non-homologous end-joining [PATH:hsa03450] |
名称 |
---|
2-LTR circle formation |
Cytosolic sensors of pathogen-associated DNA |
Disease |
DNA Repair |
Double-Strand Break Repair |
Early Phase of HIV Life Cycle |
HIV Infection |
HIV Life Cycle |
Infectious disease |
Innate Immune System |
Integration of provirus |
IRF3-mediated induction of type I IFN |
Nonhomologous End-joining (NHEJ) |
Processing of DNA ends prior to end rejoining |
STING mediated induction of host immune responses |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Malignant neoplasm of breast | 0.012920927 | 8 | 0 | BeFree_GAD |
Malignant neoplasm of urinary bladder | 0.010282454 | 5 | 0 | BeFree_GAD |
Malignant neoplasm of lung | 0.008186863 | 7 | 0 | BeFree_GAD |
Multiple Myeloma | 0.006448592 | 5 | 0 | BeFree_GAD_LHGDN |
Adenocarcinoma | 0.005634266 | 3 | 0 | BeFree_GAD_LHGDN |
Squamous cell carcinoma | 0.005634266 | 3 | 0 | BeFree_GAD_LHGDN |
Chronic Obstructive Airway Disease | 0.005276948 | 3 | 0 | BeFree_GAD |
Head and Neck Neoplasms | 0.004734064 | 2 | 0 | GAD |
melanoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
Neuroectodermal Tumors | 0.002995792 | 1 | 0 | BeFree_LHGDN |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。